Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection
dc.contributor.author | Foster, GR | en_US |
dc.contributor.author | Afdhal, N | en_US |
dc.contributor.author | Roberts, SK | en_US |
dc.contributor.author | Braeu, N | en_US |
dc.contributor.author | Gane, EJ | en_US |
dc.contributor.author | Pianko, S | en_US |
dc.contributor.author | Lawitz, E | en_US |
dc.contributor.author | Thompson, A | en_US |
dc.contributor.author | Shiffman, ML | en_US |
dc.contributor.author | Cooper, C | en_US |
dc.contributor.author | Towner, WJ | en_US |
dc.contributor.author | Conway, B | en_US |
dc.contributor.author | Ruane, P | en_US |
dc.contributor.author | Bourliere, M | en_US |
dc.contributor.author | Asselah, T | en_US |
dc.contributor.author | Berg, T | en_US |
dc.contributor.author | Zeuzem, S | en_US |
dc.contributor.author | Rosenberg, W | en_US |
dc.contributor.author | Agarwal, K | en_US |
dc.contributor.author | Stedman, CAM | en_US |
dc.contributor.author | Mo, H | en_US |
dc.contributor.author | Dvory-Sobol, H | en_US |
dc.contributor.author | Han, L | en_US |
dc.contributor.author | Wang, J | en_US |
dc.contributor.author | McNally, J | en_US |
dc.contributor.author | Osinusi, A | en_US |
dc.contributor.author | Brainard, DM | en_US |
dc.contributor.author | McHutchison, JG | en_US |
dc.contributor.author | Mazzotta, F | en_US |
dc.contributor.author | Tran, TT | en_US |
dc.contributor.author | Gordon, SC | en_US |
dc.contributor.author | Patel, K | en_US |
dc.contributor.author | Reau, N | en_US |
dc.contributor.author | Mangia, A | en_US |
dc.contributor.author | Sulkowski, M | en_US |
dc.contributor.author | Investigators, AA | en_US |
dc.date.accessioned | 2016-11-28T14:21:26Z | |
dc.date.issued | 2015-12-31 | en_US |
dc.date.submitted | 2016-09-27T13:04:05.323Z | |
dc.identifier.issn | 0028-4793 | en_US |
dc.identifier.other | 10.1056/NEJMoa1512612 | |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/17933 | |
dc.format.extent | 2608 - 2617 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | NEW ENGLAND JOURNAL OF MEDICINE | en_US |
dc.rights | All rights reserved | |
dc.title | Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection | en_US |
dc.type | Article | |
dc.rights.holder | 2015 Massachusetts Medical Society | |
dc.identifier.doi | 10.1056/NEJMoa1512612 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000367374100006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 27 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 373 | en_US |
Files in this item
This item appears in the following Collection(s)
-
Centre for Immunobiology [1153]